Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01268904

Enrollment

Registered

2010-12-31

Start date

2011-01-31

Completion date

2013-08-31

Last updated

2010-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Status Epilepticus

Brief summary

To evaluate the safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures as part of seizure treatment protocol in pediatric ER

Interventions

DRUGValproate

Intravenous valproate application to pediatric patients suffering from status epilepticus and acute repetitive seizures

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Months to 18 Years

Healthy volunteers

Inclusion criteria

* Child with clinical presentation of status epilepticus

Exclusion criteria

* All others

Design outcomes

Primary

Measure	Time frame
Safety of intravenous valproate in pediatric status epilepticus	One week

Secondary

Measure	Time frame
Efficacy of intravenous valproate in pediatric status epilepticus	One week

Countries

Israel

Contacts

Primary ContactIyad Magadly, MD

magadly@gmail.com972-4-6304331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026